Clinical Trial Update: Efficacy and Safety of Omalizumab in Patients With Severe Persistent Asthma [Phase 3]

View source ↗

Summary

This document reports results from a Phase 3 trial evaluating the efficacy and safety of omalizumab in patients with severe persistent asthma. The update summar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Omalizumab (Omalizumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Asthma | Phase 3 | Status: COMPLETED